Molbio Diagnostics IPO
MOLBIO · Hospital & Healthcare Services · BSE,NSE
IPO Opportunity Score
60/100
Average Opportunity
Apply?
Selective Apply
Risk
Moderate
Est. listing gain
—
Retail allotment odds
1.2%
HNI allotment odds
2%
Mixed signals — selective apply only if thesis fits your risk appetite. Prefer 1 lot to limit capital blocked.
Retail and HNI allotment odds are illustrative (often using total subscription as a proxy when category-wise data is unavailable).
Price band
₹768 – ₹807
GMP
—
Est. listing
—
Issue size
₹940 Cr
Subscription
81.7x
Min. investment
₹14,526
About the company
Company summary is not available yet for this IPO. Check the RHP/DRHP for the official business description.
Issue details
Timeline
Registrar
KFin Technologies Limited
Contact: M. Murali Krishna
Phone: +91 40 6716 2222 / 1800 3094001
molbio.ipo@kfintech.comVisit registrar website →Documents
IPO data from Upstox; GMP from unofficial grey-market aggregators. GMP is not regulated and does not guarantee listing performance. Scorecard uses GMP + subscription heuristics — not investment advice.
About Molbio Diagnostics IPO IPO
IPO detail with price band, GMP, scorecard, subscription heat, timeline and registrar links.
How it works
Review the opportunity score and documents (RHP/DRHP), then use allotment or GMP calculators.
Practical tips
Note allotment and listing dates on your calendar before you apply.
Important to know
GMP and scores are informational — not apply advice.
Frequently Asked Questions
- What details are shown for Molbio Diagnostics IPO?
- Company summary, price band, timeline, lot size, and grey-market premium (GMP) when the data source provides them.
- What is GMP and should I trust it?
- GMP is an unofficial grey-market indication of listing sentiment. It can reverse quickly and is not a guarantee of listing gains.
- Can I apply for the IPO on EnrichReturns?
- No. Apply via ASBA through your bank or broker UPI flow as per the exchange process.
- Where should I read official risk disclosures?
- Always read the Red Herring Prospectus (RHP) and exchange filings. This page is informational, not investment advice.
- How fresh is subscription and GMP data?
- Figures depend on upstream feeds and may lag. Confirm live subscription on NSE/BSE and treat GMP as speculative.
- Is SME different from mainboard?
- Yes. SME IPOs have different lot sizes, eligibility, and liquidity profiles. Check the issue type before applying.